参考文献

1.张志愿.口腔颌面外科学.8版.北京：人民卫生出版社，2020.

2.CHI A C，DAY T A，NEVILLE B W.Oral cavity and oropharyngeal squamous cell carcinoma--an update.CA Cancer J Clin，2015，65（5）：401-421.

3.CHEN M C，FENG I J，LU C H，et al.The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma：a population-based study in Taiwan over a 25-year period（1979-2003）.Ann Oncol，2008，19：1180-1186.

4.WHITEMAN D C.Hot tea and increased risk of oesophageal cancer.BMJ，2009，338：b610.

5.GREEN A C，OLSEN C M.Cutaneous squamous cell carcinoma：an epidemiological review.Br J Dermatol，2017，177（2）：373-381.

6.MCCORMACK V A，AGUDO A，DAHM C C，et al.Cigar and pipe smoking and cancer risk in the European Prospective Investigation into Cancer and Nutrition（EPIC）.Int J Cancer，2010，127（10）：2402-2411.

7.DASANAYAKE A P，SILVERMAN A J，WARNAKULASURIYA S.Maté drinking and oral and oro-pharyngeal cancer：a systematic review and meta-analysis.Oral Oncol，2010，46（2）：82-86.

8.MCLAUGHLIN J K，GRIDLEY G，BLOCK G，et al.Dietary factors in oral and pharyngeal cancer.J Natl Cancer Inst，1988，80（15）：1237-1243.

9.REN J S，FREEDMAN N D，KAMANGAR F，et al.Tea，coffee，carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study.Eur J Cancer，2010，46（10）：1873-1881.

10.GANDINI S，BOTTERI E，IODICE S，et al.Tobacco smoking and cancer：a meta-analysis.Int J Cancer，2008，122（1）：155-164.

11.TRUATI F，GARAVELLO W，TRAMACERE I，et al.A meta-analysis of alcohol drinking and oral and pharyngeal cancers：results from subgroup analyses.Alcohol Alcohol，2013，48（1）：107-118.

12.LACHENMEIER D W，MONAKHOVA Y B.Short-term salivary acetaldehyde increase due to direct exposure to alcoholic beverages as an additional cancer risk factor beyond ethanol metabolism.J Exp Clin Cancer Res，2011，30（1）：3.

13.PETTI S，MOHD M，SCULLY C.Revisiting the association between alcohol drinking and oral cancer in nonsmoking and betel quid non-chewing individuals.Cancer Epidemiol，2012，36（1）：e1-e6.

14.GUHA N，WARNAKULASURIYA S，VLAANDEREN J，et al.Betel quid chewing and the risk of oral and oropharyngeal cancers：a meta-analysis with implications for cancer control.Int J Cancer，2014，135（6）：1433-1443.

15.PETTI S.Lifestyle risk factors for oral cancer.Oral Oncol，2009，45（4-5）：340-350.

16.HASHIM D，GENDEN E，POSNER M，et al.Head and neck cancer prevention：from primary prevention to impact of clinicians on reducing burden，Ann Oncol，2019，30（5）：744-756.

17.ACHARYA S，EKALAKSANANAN T，VATANASAPT P，et al.Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study.J Oral Pathol Med，2015，44（4）：252-257.

18.DE LIMA M A P，TEODORO I P P，GALIZA L E，et al.Association between Epstein-Barr virus and oral carcinoma：a systematic review with meta-analysis.Crit Rev Oncog，2019，24（4）：349-368.

19.POLZ-GRUSZKA D，MORSHED K，JARZYNSKI A，et al.Prevalence of polyoma BK virus（BKPyV），Epstein-Barr virus（EBV）and human papilloma virus（HPV）in oropharyngeal cancer.Pol J Microbiol，2015，64（4）：323-328.

20.BORSETTO D，FUSSEY J，FABRIS L，et al.HCV infection and the risk of head and neck cancer：a meta-analysis.Oral Oncol，2020，109：104869.

21.SU T H，TSENG T C，LIU C J，et al.Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.Int J Cancer，2020，147（3）：901-908.

22.GOPINATH D，MENON R K，VEETTIL S K，et al.Periodontal diseases as putative risk factors for head and neck cancer：systematic review and meta-analysis.Cancers（Basel），2020，12（7）：1893.

23.BARROS S P，FAHIMIPOUR F，TARRAN R，et al.Epigenetic reprogramming in periodontal disease：dynamic crosstalk with potential impact in oncogenesis.Periodontol 2000，2020，82（1）：157-172.

24.SAMI A，ELIMAIRI I，STANTON C，et al.The Role of the microbiome in oral squamous cell carcinoma with insight into the microbiome-treatment axis.Int J Mol Sci，2020，21（21）：8061.

25.HEALY C M，MORAN G P.The microbiome and oral cancer：more questions than answers.Oral Oncol，2019，89：30-33.

26.PARK B J，CHIOSEA S I，GRANDIS J R.Molecular changes in the multistage pathogenesis of head and neck cancer.Cancer Biomark，2010，9（1-6）：325-339.

27.MURUGAN A K，MUNIRAJAN A K，TSUCHIDA N.Ras oncogenes in oral cancer：the past 20 years.Oral Oncol，2012，48（5）：383-392.

28.CHAI A W Y，LIM K P，CHEONG S C.Translational genomics and recent advances in oral squamous cell carcinoma.Semin Cancer Biol，2020，61：71-83.

29.MOUNTZIOS G，RAMPIAS T，PSYRRI A.The mutational spectrum of squamous-cell carcinoma of the head and neck：targetable genetic events and clinical impact.Ann Oncol，2014，25（10）：1889-1900.

30.WILKIE M D，LAU A S，VLATKOVIC N，et al.Metabolic signature of squamous cell carcinoma of the head and neck：consequences of TP53 mutation and therapeutic perspectives.Oral Oncol，2018，83：1-10.

31.SAADA-BOUZID E，PEYRADE F，GUIGAY J.Molecular genetics of head and neck squamous cell carcinoma.Curr Opin Oncol，2019，31（3）：131-137.

32.KANG H，KIESS A，CHUNG C H.Emerging biomarkers in head and neck cancer in the era of genomics.Nat Rev Clin Oncol，2015，12（1）：11-26.

33.FERRIS R L.Immunology and immunotherapy of head and neck cancer.J Clin Oncol，2015，33（29）：3293-3304.

34.ARTHUR A E，GOSS A M，DEMARK-WAHNEFRIDE W，et al.Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients：results from a prospective cohort study.Int J Cancer，2018，143（5）：1105-1113.

35.RAMOS-GARCIA P，ROCA-RODRIGUEZ M D M，AGUILAR-DIOSDADO M，et al.Diabetes mellitus and oral cancer/oral potentially malignant disorders：a systematic review and meta-analysis.Oral Dis，2021，27（3）：404-421.

36.WANG Y，ZHANG X，WANG Z，et al.LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis.Cancer Lett，2018，434：172-183.

37.NCD RISK FACTOR COLLABORATION（NCD-RISC）.Trends in adult body-mass index in 200 countries from 1975 to 2014：a pooled analysis of 1698 population-based measurement studies with 19.2 million participants.Lancet，2016，387（10026）：1377-1396.

38.KARNELL L H，SPERRY S M，ANDERSON C M，et al.Influence of body composition on survival in patients with head and neck cancer.Head Neck，2016，38（Suppl1）：E261-E267.

39.ALBERGOTTI W G，DAVIS K S，ABBERBOCK S，et al.Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinoma.Oral Oncol，2016，60：55-60.

40.IYENGAR N M，KOCHHAR A，MORRIS P G，et al.Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.Cancer，2014，120（7）：983-991.

41.HU Q，PENG J，CHEN X，et al.Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.Oral Oncol，2019，89：14-22.

42.HENSLEY C T，WASTI A T，DEBERARDINIS R J.Glutamine and cancer：cell biology，physiology，and clinical opportunities.J Clin Invest，2013，123（9）：3678-3684.

43.YANG X H，JING Y，WANG S，et al.Integrated non-targeted and targeted metabolomics uncovers amino acid markers of oral squamous cell carcinoma.Front Oncol，2020，10：426.

44.LUO Y，LI W，LING Z，et al.ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.Cancer Med，2020，9（10）：3489-3499.

45.EDEFONTI V，HASHIBE M，AMBROGI F，et al.Nutrient-based dietary patterns and the risk of head and neck cancer：a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.Ann Oncol，2012，23（7）：1869-1880.

46.LAWAL A O，KOLUDE B，ADEYEMI B F，et al.Serum antioxidant vitamins and the risk of oral cancer in patients seen at a tertiary institution in Nigeria.Niger J Clin Pract，2012，15（1）：30-33.

47.GRIMM M，CETINDIS M，BIEGNER T，et al.Serum vitamin D levels of patients with oral squamous cell carcinoma（OSCC）and expression of vitamin D receptor in oral precancerous lesions and OSCC.Med Oral Patol Oral Cir Bucal，2015，20（2）：e188-195.

48.LIPWORTH L，ROSSI M，MCLAUGHLIN J K，et al.Dietary vitamin D and cancers of the oral cavity and esophagus.Ann Oncol，2009，20（9）：1576-1581.

49.CIRMI S，NAVARRA M，WOODSIDE J V，et al.Citrus fruits intake and oral cancer risk：a systematic review and metaanalysis.Pharmacol Res，2018，133：187-194.

50.KAWAKITA D，LEE Y A，TURATI F，et al.Dietary fiber intake and head and neck cancer risk：a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.Int J Cancer，2017，141（9）：1811-1821.

51.FURQUIM C P，PIVOVAR A，AMENABAR J M，et al.Oral cancer in Fanconi anemia：review of 121 cases.Crit Rev Oncol Hematol，2018，125：35-40.

52.AMENABAR J M，TORRES-PEREIRA C C，TANG K D，et al.Two enemies，one fight：an update of oral cancer in patients with Fanconi anemia.Cancer，2019，125（22）：3936-3946.

53.RAY J G，SWAIN N，GHOSH R，et al.Dyskeratosis congenita with malignant transformation.BMJ Case Rep，2011，2011：bcr0320102848.

54.RIECHELMANN H.Occupational exposure and cancer of the oral cavity and pharynx.Laryngorhinootologie，2002，81（8）：573-579.

55.CASH E，DUCK C R，BRINKMAN C，et al.Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival.Psychooncology，2018，27（10）：2500-2507.

56.VISWANATHAN V，JULURI R，GOEL S，et al.Apoptotic index and proliferative index in premalignant and malignant squamous cell lesions of the oral cavity.J Int Oral Health，2015，7（1）：40-43.

57.DWIVEDI R，CHANDRA S，MEHROTRA D，et al.Predicting transition from oral pre-malignancy to malignancy via Bcl-2 immuno-expression：evidence and lacunae.J Oral Biol Craniofac Res，2020，10（4）：397-403.

58.CAMISASCA D R，HONORATO J，BERNARDO V，et al.Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.Oral Oncol，2009，45（3）：225-233.

59.JOHNSTONE S，LOGAN R M.Expression of vascular endothelial growth factor（VEGF）in normal oral mucosa，oral dysplasia and oral squamous cell carcinoma.Int J Oral Maxillofac Surg，2007，36（3）：263-266.

60.STASIKOWSKA-KANICKA O，WĄGROWSKA-DANILEWICZ M，DANILEWICZ M.T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.J Oral Pathol Med，2018，47（2）：136-143.

61.WEBER M，WEHRHAN F，BARAN C，et al.Malignant transformation of oral leukoplakia is associated with macrophage polarization.J Transl Med，2020，18（1）：11.

62.ZHANG L，LIU Y，ZHENG H J，et al.The oral microbiota may have influence on oral cancer.Front Cell Infect Microbiol，2020，9：476.

63.TABERNA M，MENA M，PAVÓN M A，et al.Human papillomavirus-related oropharyngeal cancer.Ann Oncol，2017，28（10）：2386-2398.

64.SYRJÄNEN K，SYRJÄNEN S，LAMBERG M，et al.Morphological and immunohistochemical evidence suggesting human papillomavirus（HPV）involvement in oral squamous cell carcinogenesis.Int J Oral Surg，1983，12（6）：418-424.

65.ZUR HAUSEN H.Papillomaviruses and cancer：from basic studies to clinical application.Nat Rev Cancer，2002，2（5）：342-350.

66.MUZAFFAR J，BARI S，KIRTANE K，et al.Recent advances and future directions in clinical management of head and neck squamous cell carcinoma.Cancers（Basel），2021，13（2）：338.

67.KOSTARELI E，HOLZINGER D，HESS J.New concepts for translational head and neck oncology：lessons from hpv-related oropharyngeal squamous cell carcinomas.Front Oncol，2012，2：36.

68.CASTELLSAGUÉ X，MENA M，ALEMANY L.Epidemiology of HPV-positive tumors in europe and in the world.Recent Results Cancer Res，2017，206：27-35.

69.DE MARTEL C，FERLAY J，FRANCESCHI S，et al.Global burden of cancers attributable to infections in 2008：a review and synthetic analysis.Lancet Oncol，2012，13（6）：607-615.

70.MEHANNA H，BEECH T，NICHOLSON T，et al.Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region.Head Neck，2013，35（5）：747-755.

71.NDIAYE C，MENA M，ALEMANY L，et al.HPV DNA，E6/E7 mRNA，and p16INK4a detection in head and neck cancers：a systematic review and meta-analysis.Lancet Oncol，2014，15（12）：1319-1331.

72.NI G，HUANG K，LUAN Y，et al.Human papillomavirus infection among head and neck squamous cell carcinomas in southern China.PLoS One，2019，14（9）：e0221045.

73.LAM E W，CHAN J Y，CHAN A B，et al.Prevalence，clinicopathological characteristics，and outcome of human papillomavirus-associated oropharyngeal cancer in southern chinese patients.Cancer Epidemiol Biomarkers Prev，2016，25（1）：165-173.

74.GUO L，YANG F，YIN Y，et al.Prevalence of human papillomavirus type-16 in head and neck cancer among the chinese population：a meta-analysis.Front Oncol，2018，8：619.

75.MARUR S，D'SOUZA G，WESTRA W H，et al.HPV-associated head and neck cancer：a virus-related cancer epidemic.Lancet Oncol，2010，11（8）：781-789.

76.GILLISON M L，D'SOUZA G，WESTRA W，et al.Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.J Natl Cancer Inst，2008，100（6）：407-420.

77.DAHLSTROM K R，LI G，TORTOLERO-LUNA G，et al.Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.Head Neck，2011，33（6）：847-855.

78.KLUSSMANN J P，WEISSENBORN S J，WIELAND U，et al.Prevalence，distribution，and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.Cancer，2001，92（11）：2875-2884.

79.MIRGHANI H，AMEN F，MOREAU F，et al.Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma？ Oral Oncol，2015，51（3）：229-236.

80.D'Souza G，Zhang H H，D'Souza W D，et al.Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer.Oral Oncol，2010，46（2）：100-104.

81.HONG A M，MARTIN A，CHATFIELD M，et al.Human papillomavirus，smoking status and outcomes in tonsillar squamous cell carcinoma.Int J Cancer，2013，132（12）：2748-2754.

82.MAXWELL J H，KUMAR B，FENG F Y，et al.Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.Clin Cancer Res，2010，16（4）：1226-1235.

83.SOOD A J，MCILWAIN W，O'CONNELL B，et al.The association between T-stage and clinical nodal metastasis in HPV-positive oropharyngeal cancer.Am J Otolaryngol，2014，35（4）：463-468.

84.VOJTECHOVA Z，SABOL I，SALAKOVA M，et al.Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.Int J Cancer，2016，138（2）：386-395.

85.LIM M Y，DAHLSTROM K R，STURGIS E M，et al.Human papillomavirus integration pattern and demographic，clinical，and survival characteristics of patients with oropharyngeal squamous cell carcinoma.Head Neck，2016，38（8）：1139-1144.

86.CHATURVEDI A K，GRAUBARD B I，BROUTIAN T，et al.Effect of prophylactic human papillomavirus（HPV）vaccination on oral HPV infections among young adults in the united states.J Clin Oncol，2018，36（3）：262-267.

87.HERRERO R，QUINT W，HILDESHEIM A，et al.Reduced prevalence of oral human papillomavirus（HPV）4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.PLoS One，2013，8（7）：e68329.

88.PINTO L A，KEMP T J，TORRES B N，et al.Quadrivalent human papillomavirus（HPV）vaccine induces HPV-specific antibodies in the oral cavity：results from the mid-adult male vaccine trial.J Infect Dis，2016，214（8）：1276-1283.

89.HIRTH J M，CHANG M，RESTO V A，et al.Prevalence of oral human papillomavirus by vaccination status among young adults（18-30years old）.Vaccine，2017，35（27）：3446-3451.